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Abstract
Background: Driving pressure (ΔPrs) across the respiratory system is suggested as the strongest predictor of
hospital mortality in patients with acute respiratory distress syndrome (ARDS). We wonder whether this result
is related to the range of tidal volume (VT). Therefore, we investigated ΔPrs in two trials in which strict lung-
protective mechanical ventilation was applied in ARDS. Our working hypothesis was that ΔPrs is a risk factor
for mortality just like compliance (Crs) or plateau pressure (Pplat,rs) of the respiratory system.
Methods: We performed secondary analysis of data from 787 ARDS patients enrolled in two independent
randomized controlled trials evaluating distinct adjunctive techniques while they were ventilated as in the
low VT arm of the ARDSnet trial. For this study, we used VT, positive end-expiratory pressure (PEEP), Pplat,rs,
Crs, ΔPrs, and respiratory rate recorded 24 hours after randomization, and compared them between survivors
and nonsurvivors at day 90. Patients were followed for 90 days after inclusion. Cox proportional hazard modeling was
used for mortality at day 90. If colinearity between ΔPrs, Crs, and Pplat,rs was verified, specific Cox models were used
for each of them.
Results: Both trials enrolled 805 patients of whom 787 had day-1 data available, and 533 of these survived. In the
univariate analysis, ΔPrs averaged 13.7 ± 3.7 and 12.8 ± 3.7 cmH2O (P = 0.002) in nonsurvivors and survivors, respectively.
Colinearity between ΔPrs, Crs and Pplat,rs, which was expected as these variables are mathematically coupled, was
statistically significant. Hazard ratios from the Cox models for day-90 mortality were 1.05 (1.02–1.08) (P = 0.005), 1.05
(1.01–1.08) (P = 0.008) and 0.985 (0.972–0.985) (P = 0.029) for ΔPrs, Pplat,rs and Crs, respectively. PEEP and VT were not
associated with death in any model.
Conclusions: When ventilating patients with low VT, ΔPrs is a risk factor for death in ARDS patients, as is Pplat,rs or Crs.
As our data originated from trials from which most ARDS patients were excluded due to strict inclusion and exclusion
criteria, these findings must be validated in independent observational studies in patients ventilated with a
lung protective strategy.
Trial registration: Clinicaltrials.gov NCT00299650. Registered 6 March 2006 for the Acurasys trial.
Clinicaltrials.gov NCT00527813. Registered 10 September 2007 for the Proseva trial.
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Background
Lung protective ventilation, which is a current strong
recommendation in patients with the acute respiratory
distress syndrome (ARDS), includes several components,
the most important of them being lowering tidal volume
(VT) and limiting plateau (Pplat,rs) equal to or below
30 cm H2O. This combined strategy is indeed the single
ventilator intervention that has been shown to signifi-
cantly improve survival so far [1]. This trial introduced
scaling of VT to the predicted body weight. However, in
the lower VT group with the significant improvement in
survival, VT was not strictly set to 6 ml/kg but may have
been accommodated in the range 4–8 ml/kg. VT is equal
to the difference between plateau (Pplat,rs) and total
positive end-expiratory pressure (PEEPtot,rs) measured
at zero flow divided by the compliance of the respiratory
system (Crs). The difference between Pplat,rs and PEEP-
tot,rs is the driving pressure (ΔPrs). Therefore, using
ΔPrs to select VT is equivalent to titrating VT for Crs, as
VT is equal to ΔPrs divided by Crs.
The first report suggesting that ΔPrs is associated with
mortality came from the study by Amato et al. [2].
Recently a retrospective analysis of several trials in
patients with ARDS comparing different PEEP levels at
the same VT or different VT levels at the same PEEP, or
a combination of both, found that ΔPrs is the stronger
predictor of mortality as compared with Pplat,rs [3].
Furthermore, the relative risk of mortality significantly
increased above a threshold in the vicinity of 15 cm
H2O. It is important to emphasize at this point that the
threshold of a driving pressure of 14 or 15 cmH2O to
predict outcome or titrate VT has not been validated or
confirmed. With the aim of attempting to confirm this
finding, we also wondered whether this result may be
due to the wide range of VT used across the trials
included. To try to answer this question, we investigated
ΔPrs from two trials [4, 5] in which strict lung-
protective mechanical ventilation, in particular 6 ml/kg
predicted body weight VT, was applied to patients with
ARDS. Our working hypothesis was that ΔPrs was asso-
ciated with death, just like compliance (Crs) or Pplat,rs.
Methods
This is a secondary analysis of patients enrolled in two
previously published randomized controlled trials,
namely Acurasys [4] and Proseva [5]. The first trial com-
pared the neuromuscular blocking agent (NMBA) cisa-
tracurium to placebo and the second compared the
prone to the supine position. Both had similar inclusion
criteria (notably early ARDS and partial pressure of
oxygen in arterial blood (PaO2)/oxygen fraction in air
(FIO2) <150 mm Hg under PEEP ≥5 cm H2O) and simi-
lar lung-protective mechanical ventilation (in particular
6 ml/kg predicted body weight VT, limited Pplat,rs and
PEEP/FIO2 table [1]). ARDS was identified based on the
American-European consensus definition criteria [6].
Both trials identified significant survival benefit in the
experimental group.
From the case report form of each original trial, we
extracted the relevant variables for the present study,
namely sequential organ failure assessment (SOFA)
score, continuous NMBA infusion, prone position, pH,
partial pressure of carbon dioxide in arterial blood
(PaCO2), PaO2/FIO2, lactate, respiratory rate, VT, PEEP,
Pplat,rs, Crs and ΔPrs, which were recorded at day 1 as
the values corresponding to those gathered 24 hours
after randomization in each trial. In addition, we used
gender, age and simplified acute physiology score (SAPS)
II recorded at the time of admission and compared
between survivors and nonsurvivors at day 90. The allo-
cation assignment in the two trials was entered as prede-
fined covariates into the models. Furthermore, as recent
experimental data suggest that the amount of energy
transferred from the ventilator into the lung may be a
contributing factor to ventilator-induced lung injury
(VILI) [7], we computed the mechanical power as ΔPrs ×
VT × respiratory rate. It was expressed as J/min and was
included in the analysis in the present study.
Descriptive statistics included percentages for categor-
ical variables and means and standard deviation (SD) for
continuous variables and were compared using nonpara-
metric tests. Cox proportional hazard models were used
with covariates significantly different between survivors
and non survivors at the threshold of 0.20 and mortality
at day 90 as the dependent variable. Even though ΔPrs,
Crs, and Pplat,rs are mathematically coupled, we
planned to formally test the collinearity within them
and, if verified, to use a specific Cox model for each.
Because pH and lactate interact, we used their inter-
action term in the Cox models. We also included those
collinear variables two-by-two into four additional Cox
regression models, besides the other covariates. One
model pertained to Pplat,rs and ΔPrs, one to Crs and
ΔPrs, one to ΔPrs and mechanical power, and one to
Crs and Pplat,rs. Two interpretations of the results could
a priori be deciphered. If both variables in the couple
lacked significance, the conclusion could be that the
same information was carried by each component of
the couple. If one of the variables in the couple
remained significantly correlated with survival, this
variable would be more informative than the other in
the couple. Univariate and multivariate Cox propor-
tional hazard regression models were used to estimate
the hazard ratio (HR).
Kaplan-Meier graphs were used to express the prob-
ability of death from inclusion to day 90 and were com-
pared across groups by the log rank test. Groups were
defined from the median values in the present cohort.
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We split ΔPrs into five quintiles of almost 150 patients
each following the method used in both the Amato [3]
and the Lung Safe [8] studies by using the Ntiles func-
tion in SPSS software. Comparison between quintiles
was made by analysis of variance (ANOVA) with post-
hoc comparison from the first quintile performed using
the Tukey test. A p value <0.05 was considered signifi-
cant. The statistical analysis was conducted using IBM
SPSS Statistics, version 20.0 (IBM SPSS Inc., Chicago,
IL, USA).
Results
A total of 805 patients were included in the two trials, of
these patient, 787 had data available at day 1. There
were 533 survivors and 254 non-survivors at day 90
(mortality rate 32.3% for the combined trials). The
comparison between survivors and non survivors at day
90 is shown in Table 1.
As the collinearity between ΔPrs, mechanical power,
Pplat,rs and Crs was statistically significant, a Cox model
was constructed for each of these variables. The Cox
model pertaining to ΔPrs is shown in Table 2. Age,
SOFA, prone position, pH, lactate, pH and its interaction
with lactate and ΔPrs were significantly associated with
the outcome at day 90 whilst NMBA was not. For each
of the additional three Cox models that included mech-
anical power, Pplat,rs, or Crs as a single covariable, the
significant predictors of patient outcome were the same
as for ΔPrs (see additional files 1, 2 and 3). The HR was
high for lactate in each Cox model, with wide confidence
intervals (Table 2 and Additional files 1, 2 and 3). After
multiple adjustments of coupled variables, four add-
itional Cox models were performed (Additional file 4).
ΔPrs and Pplat,rs remained significantly associated with
patient outcome, meaning that each of them brought
specific and distinct information (model 1 in Additional
file 4). For ΔPrs and mechanical power, ΔPrs maintained
a significant association with mortality at day 90, and
hence carries specific information (model 2 in
Additional file 4). However, for ΔPrs and Crs, and for
Pplat,rs and Crs (models 3 and 4, respectively, in
Additional file 4), neither of the variables in each pair
were statistically significant. Therefore, it could be
concluded that ΔPrs and Crs, on one hand, and
Pplat,rs and Crs on the other hand, share the same
information.
Figure 1 displays the unadjusted mortality rates at day
90 across five quintiles of ΔPrs (Fig. 1a), mechanical
power (Fig. 1b), Pplat,rs (Fig. 1c) and Crs (Fig. 1d). No
distinct threshold of ΔPrs was identified (Fig. 1).
Table 1 Characteristics at the time of inclusion or day 1 between survivors and non-survivors at day 90
Variables All (n = 787) Survivors (n = 533) Nonsurvivors (n = 254) P
Male gender 542 (68.9) 366 (68.7) 176 (69.3) 0.923
Age, years 59 ± 16 56 ± 15 66 ± 14 <0.001
SAPS II on ICU admission 45 ± 15 45 ± 16 51 ± 15 <0.001
SOFA score on day 1 7 ± 4 7 ± 4 9 ± 4 <0.001
Continuous NMBA as allocation group 173 (22.0) 117 (22.0) 56 (22.0) 0.976
Prone position as allocation group 233 (34.4) 181 (34.0) 52 (20.5) <0.001
Arterial pH on day 1 7.35 ± 0.09 7.36 ± 0.08 7.32 ± 0.10 <0.001
PaCO2 on day 1, mmHg 47 ± 11 46 ± 11 47 ± 11 0.076
PaO2/FIO2 ratio on day 1 159 ± 74 163 ± 76 152 ± 68 0.056
Lactate on day 1, mmol/L 2.0 ± 1.9 1.8 ± 1.6 2.4 ± 2.2 <0.001
Respiratory rate on day 1,/minute 27 ± 6 26 ± 5 27 ± 6 0.010
Tidal volume on day 1, ml 397 ± 76 398 ± 76 395 ± 78 0.413
Tidal volume on day 1, ml/PBW kg 6.3 ± 0.8 6.2 ± 0.8 6.3 ± 0.8 0.691
PEEP on day 1, cm H2O 10 ± 3 10 ± 3 10 ± 3 0.210
Plateau pressure on day 1, cm H2O 23 ± 4 23 ± 4 24 ± 4 <0.001
Tidal compliance on day 1, ml/cm H2O 33 ± 12 34 ± 12 31 ± 12 0.016
Driving pressure on day 1, cm H2O 13 ± 4 13 ± 4 14 ± 4 0.002
Mechanical power on day 1, J/min 13.4 ± 5.0 13.0 ± 4.8 14.3 ± 5.4 <0.001
Quantitative values are expressed as mean ± SD and qualitative values are numbers (percentage of group). Tidal compliance of respiratory system was calculated
as the ratio of tidal volume to driving pressure. Driving pressure was calculated as the difference between plateau pressure and applied positive end-expiratory
pressure (PEEP). Mechanical power was calculated as the product of driving pressure in Newton (cm H2O × 0.098), tidal volume and respiratory rate. Day 1 was
defined as the 24 hours following the inclusion. ICU intensive care unit, SAPS II simplified acute physiology score II, SOFA sequential organ failure assessment,
PaO2/FIO2 ratio the ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen, PaCO2 partial pressure of arterial carbon dioxide,
PBW predicted body weight, NMBA neuromuscular blocking agent
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The Kaplan-Meier graphs describing the probability
of survival from inclusion to 90 days for ΔPrs above
or below 13 cm H2O and for mechanical power
above or below 12 J/min at day 1 are shown in Fig. 2.
The survival was significantly higher in patients with
ΔPrs ≤13 cm H2O at day 1 than in those with ΔPrs
>13 cm H2O and in patients with mechanical power
≤12 J/min at day 1 than in those with mechanical
power >12 J/min. Survival was significantly higher in
patients with Pplat,rs <23 cm H2O than in those
with Pplat,rs ≥23 cm H2O and higher in patients
with Crs <31 ml/cmH2O than in those with Crs
≥31 ml/cmH2O (see Additional file 5).
Whereas the unadjusted probabilities of survival
were linearly related to quintiles of ΔPrs, mechanical
power, Pplat,rs, and Crs (Fig. 1), their corresponding
adjusted counterparts displayed a threshold in the
vicinity of 15 cmH2O, 15 J/min, 26 cmH2O, and
26 ml/cmH2O, respectively (Fig. 3). The adjusted
survival curves derived from the Cox regression
analysis are shown for ΔPrs and mechanical power
(see Additional file 6) and for Pplat,rs and Crs (see
Additional file 7).
Discussion
The main findings of the present study in our unique
cohort were that: (1) ΔPrs was significantly associated
with patient outcome after controlling for confound-
ing factors, (2) survival was significantly higher in
patients with ΔPrs ≤13 cm H2O at day 1, (3) survival
was significantly higher in patients with mechanical
power ≤12 J/min at day 1 and in patients with Pplat
< 23 cmH2O, and (4) the information given by ΔPrs
and Crs is similar. Our main finding was that with
VT and Pplat controlled, ΔPrs brings little more add-
itional information independently on Pplat and Crs.
Driving pressure
Rather than confirming the results of Amato et al.
[3], the present findings disclosed the limitation of
the prognostic role of ΔPrs when Plat,rs, VT, and
PEEP are strictly controlled and set according to the
ARMA trial. However, we found that the HR of ΔPrs
was similar in Amato’s study and in the present in-
vestigation. In Amato’s study, in the Cox analysis
ΔPrs was associated with 41% increased risk of mor-
tality among the 3080 patients used in the combined
analysis [3]. In this study, the authors used a 1-SD
increment in ΔPrs for calculating HR, which repre-
sented 7 cmH2O. Thus, when calculating the HR for
1 cmH2O increment, this was associated with a HR
of 1.049, which is very close to the present result, as
shown in Table 2.
In our study, per each cm H2O increase, ΔPrs was
associated with 5% increase in the risk of death,
which is in the same order of magnitude as Pplat,rs,
which was also significantly associated with mortality.
PEEP and VT were not significantly associated with
mortality in the present cohort, whilst these were
associated with a significant 2% and 3% increase in
mortality per 1 cm H2O and per 1 ml/kg PBW, re-
spectively, in Amato’s study [3]. This can be explained
by the narrower range of PEEP and VT used in our
cohort. Therefore, in contrast to Amato’s study [3]
our findings did not identify ΔPrs as the strongest
predictor of death as compared to VT, Crs, and
Pplat,rs. To explore this finding further, we used a
model-building strategy that consisted of a series of
Cox models, which included the collinear variables
two-by-two (with their interaction) and these were
then compared with the corresponding Cox models
that used the collinear variable alone. This strategy
showed that ΔPrs and Pplat,rs each provides different
information related to patient outcome. However,
interaction between them was present, statistically
meaning that the effect of each of them on outcome
was dependent on the level of the other. In other
words, the effect of one covariate modifies the effect
of the other on the outcome. When ΔPrs and mechanical
power were analyzed two-by-two, ΔPrs remained signifi-
cant but mechanical power did not. That means that ΔPrs
conveys specific information. When ΔPrs and Crs were
analyzed together neither of them remained statistically
Table 2 Multivariate Cox regression analysis for factors
including driving pressure at day 1 associated with ARDS
mortality at day 90
Variables Hazard ratio (95%
CI)
p
Age, per year 1.04 (1.03–1.05) <0.001
SOFA score on day 1, per unit 1.07 (1.03–1.11) <0.001
Continuous NMBA as allocation
group, (reference is yes)
0.64 (0.45–0.91) 0.012
Continuous prone position as
allocation group (reference is yes)
0.68 (0.47–0.98) 0.037
Respiratory rate on day 1, per unit 1.01 (0.98–1.03) 0.698
PaO2/FiO2 on day 1, per unit 1.00 (0.99–1.01) 0.831
Arterial pH on day 1, per unit 0.057 (0.009–0.371) 0.003
Lactate on day 1, per unit 18.44 (1.39–244.00) 0.027
Interaction between lactate and arterial pH
on day 1, per unit
0.67 (0.47–0.96) 0.030
Driving pressure on day 1, per unit 1.05 (1.02–1.08) 0.005
Driving pressure was calculated as the difference between plateau pressure
and applied positive end-expiratory pressure (PEEP). Day 1 was defined as
the 24 hours following the inclusion. CI confidence intervals, SOFA sequential
organ failure assessment, NMBA neuromuscular blocking agent, PaO2/FIO2 ratio
of the partial pressure of arterial oxygen to the fraction of inspired oxygen
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significantly associated with patient outcome. That means
that the same information carried by Crs is also carried by
ΔPrs. Both shared the same information. The same result,
and hence, the same interpretation also applied for
Pplat,rs and Crs.
The Lung Safe study [8] was a prospective inter-
national observational investigation in 50 countries, in
which data were collected for over 2377 patients with
ARDS in the winter season. In 703 of these patients
data were available to analyze the rate of mortality at
the time of hospital discharge over the range of ΔPrs
and Pplat,rs. The mortality rate increased linearly
with increasing ΔPrs with no threshold. The slope of
the increase in mortality over ΔPrs quintiles was
steeper than that pertaining to Pplat,rs in the Lung
safe study, whereas the slopes were similar in the
present study. However, VT was not maintained at
6 ml/kg in these two studies [3, 8] which is at vari-
ance with the present study. Furthermore, in the
Lung Safe study Pplat,rs was measured in only 40%
of the patients [8], a fact that has been highlighted
[9, 10].
ΔPrs ranged between 5 and 31 cm H2O in our cohort
(Fig. 1), which is comparable to the range of 7–32 cm
H2O in the Amato study, but wider than in the Lung
Safe study (9–25 cm H2O). It should be stressed that in
the Amato study [3] the effect of ΔPrs was related to the
adjusted relative risk of death, whereas in our study, as
in the Lung Safe study, the probability of death was
analyzed. Moreover only patients with a P/F ratio
<150 mmHg were included. ΔPrs was also reported to
be associated with death in a recent large multicenter




Fig. 1 Unadjusted mortality at day 90 across quintiles of driving pressure (a), mechanical power (bb), Pplat,rs (c) and Crs (d). The bars are
standard error of the mean (SEM). The numbers below the x axis are the numbers of patients in each quintile. P < 0.001 across quintiles
(analysis of variance). *P < 0.05 versus the first quintile
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A more relevant analysis of the data on ΔPrs would
require the knowledge of the transpulmonary ΔP
(ΔPL). Talmor et al. found that the reduction in ΔPL
was higher in an esophageal pressure-guided group
than in a control group, and that ΔPL reduction was
higher in survivors than in nonsurvivors, whereas
ΔPrs was similar in both experimental and control
groups and in survivors and nonsurvivors [12], con-
firming that the compliance of the chest wall is a key
parameter in interpreting ΔPrs and its components.
The role of ΔPL to optimize the use of mechanical
ventilation in the prone position should be further in-
vestigated, in particular regarding PEEP selection [13],
by using a physiological approach [14].
Mechanical power
The concept that the magnitude of energy trans-
ferred from the ventilator into the lung may contrib-
ute to VILI has recently arisen and has been
confirmed in an experimental study in normal pigs
receiving a combination of a large number of VT and
respiratory rates [15]. In this study mechanical
power of 12 J/min was found to promote VILI. In
the present study, our secondary goal was to explore
whether the mechanical power was associated with
the outcome. We found that this was the case and
the threshold of 12 J/min was associated with signifi-
cant distinct probabilities of survival. Interestingly,
the median value of mechanical power in the present
cohort was the same as that found experimentally as
the threshold above which VILI occurred [15]. We
also found that the value of the mechanical power in
J/min was very close to that of ΔPrs in cm H2O.
The relevance of the present data on mechanical
power should be confirmed by further investigations.
Should mechanical power be confirmed as a signifi-
cant independent predictor of survival its computa-
tion at the bedside should be recommended.
Recently, Gattinoni et al. [16] proposed using the
first-order equation to compute mechanical power.
Our present approach is much simpler and can be
easily implemented at the bedside.
The probability of survival in our study was expressed
as unadjusted and adjusted, taking into account the
covariates selected by the Cox models. This explains the
difference between the data shown in Fig. 1 and Fig. 3.
In the former, a linear relationship was observed
between survival and ΔPrs, mechanical power, Pplat,rs
and Crs. This suggests there is no safe dose of mechan-
ical ventilation. However, when the survival was adjusted
with covariates, a threshold was disclosed for the sur-
vival across quintiles.
Limitations and strengths
Our study was limited by: (1) the fact that data were
collected from two positive trials where survival was
markedly affected by the experimental approach sub-
jected to randomization; (2) as in other trials in patients
with ARDS, more than 60% of patients meeting the
criteria for ARDS were excluded from enrollment into
the trials; and (3) lack of generalizability, as patients with
PaO2/FiO2 > 150 mmHg at 24 hours were excluded
from the analysis. However, as discussed previously, our
ARDS sample was more homogeneous in terms of the
Fig. 2 Kaplan-Meier graphs of the probability of survival for 90 days
after inclusion in patients with acute respiratory distress syndrome,
according to driving pressure (a) and mechanical power (bb) at day
1. The curves were compared using the log rank test
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ventilator settings used and the present results were
highly significant.
Clinical implications
The main clinical message from our data is that if VT
and Pplat,rs are strictly maintained to 6 ml/kg pre-
dicted body weight and below 28–30 cmH2O, ΔPrs
shares the same information as Pplat,rs about the
association with day 90-mortality. Management of
patients with ARDS is an ongoing process that com-
bines physiologic [14] and pragmatic information [17].
The use of ΔPrs to manage patients as a therapeutic
target should be part of the research agenda in ARDS
[18]. However, better knowledge of the physiologic
meaning of ΔPrs is mandatory, to make sure that
ΔPrs is a relevant tool to set the ventilator adequately
in ARDS patients, as it has been done for PEEP selec-
tion [19–23]. As an example, it has been shown that
ΔPrs correlates with lung stress and, hence could
detect over-distension [24].
Conclusions
When lung protective mechanical ventilation is applied
to patients with ARDS, ΔPrs, Crs, and Pplat were risk
factors for mortality.
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variance). *P < 0.05 versus the first quintile
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